-
Stability-indicating RP-HPLC method development and validation for quantitative determination of Dexlansoprazole in bulk drug and dual delayed-release capsule
Development and ICH-compliant validation of a stability-indicating RP-HPLC method for quantitative determination of dexlansoprazole in bulk and capsule forms.
-
Overall Review on Development and Validation of RP-HPLC Method for Relugolix in Bulk and Marketed Formulations
Validated RP-HPLC assay for relugolix: Inertsil ODS-2 C18, ACN:0.1% H3PO4 (60:40), 1.0 mL/min, 293 nm; linear 20–100 µg/mL (R2=0.999), LOD 0.05 µg/mL, assay 99.12%.
